ReviewCardiovascular diabetology2024

Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide.

Fatemeh Taktaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.